Skip to main content
FinSpry Logo
FinSpry
CORT logo
CORT
(NASDAQ)
Corcept Therapeutics Incorporated
$96.66-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Corcept Therapeutics Incorporated (CORT) Stock Price & Financial Analysis

Corcept Therapeutics Incorporated Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$90.77 - $95.65
52-Week High$97.05
52-Week Low$28.66
Open$95.18
Volume1.38M
Average Volume (3M)1.11M
Market Cap10.09B
Shares Outstanding104.44M
P/E Ratio (TTM)217.10
Forward P/E482.46
Price to Sales (P/S)13.13
Price to Book (P/B)15.82
EV/EBITDA-1522.56
Revenue (TTM)769.10M
Net Income (TTM)46.50M
Free Cash Flow (TTM)119.79M
EPS (TTM)$0.40
Profit Margin6.05%
Operating Margin-1.07%
Return on Equity (ROE)7.29%
Debt to Equity0.02
50-Day MA$78.34
200-Day MA$61.28
52-Week Change41.34%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Corcept Therapeutics Incorporated

What is the current stock price for CORT?

As of the latest trading session, CORT stock trades at $90.88. The 52-week range is $28.66–$97.05, with a day range of $90.77–$95.65.

What is the P/E ratio for CORT?

Corcept Therapeutics Incorporated's trailing P/E ratio is 217.1, meaning investors pay $217.1 for every $1 of annual earnings. The forward P/E is 482.5, reflecting analyst expectations for future earnings. Corcept Therapeutics Incorporated operates in the Healthcare sector.

Does CORT pay dividends?

Corcept Therapeutics Incorporated does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CORT?

Based on 5 analysts, the consensus for CORT is Buy.

What is the market cap of CORT?

Corcept Therapeutics Incorporated's market capitalization is $9.49B, classifying it as a mid-cap company. Corcept Therapeutics Incorporated operates in the Healthcare sector within the Biotechnology industry.